SSSD 2021

 

 

PROGRAM

Thursday March 11
                     
09.00-09.10    Welcome 
 
                       Diabetes classification and precision medicine

                       (chairs: Kåre I. Birkeland, Tore Julsrud Berg) 
       
09.10-09.40    Pål Njølstad, Bergen: Monogenic diabetes
09.40-10.20    Emma Ahlqvist, Malmö: New phenotypic classification of diabetes
10.20-11.00    Markku Laakso, Kuopio: New genetic classification of diabetes

11.00-11.15    Break

11.15-12.30    Oral abstract presentations

                       (chairs: Bjørn Olav Åsvold, Malin Flodström Tullberg)
       
          O1:       Ulf Hannelius: Precision Medicine for Type 1 Diabetes - The Influence of HLA, Dose and   

                       Administration Route on the Effect of GAD-specific Immunotherapy
          O2:       Johnny Ludvigsson: Intralymphatic glutamic acid decarboxylase in recent onset Type 1 diabetes: a 

                       double-blind randomized placebo-controlled Phase IIb trial (DIAGNODE-2)
          O3:       Agnes Andersson Svärd: HLA-DRA1 intron triSNP haplotypes affect the risk of islet autoantibodies

                       in children with increased genetic risk for autoimmune type 1 diabetes
          O4:       Björn Andersson: Characterization of the human virome in a childhood Type 1 diabetes cohort 
          O5:       Dina Mansour Aly: Genetics of Kidney complications in diabetes subtypes
          O6:       Shilan Seyed Ahmadi: Risk Factors for Nephropathy in Persons with Type 1 Diabetes: A Population-

                       Based Study
          O7:       Eirik Søfteland: Sexual dysfunction in Norwegian women with type 1 diabetes: a cross-sectional

                       study 
          O8:       Mari Sørstrand Æsøy: Sexual dysfunction in women with type 1 diabetes is associated with impaired

                       autonomic function

12.40-13.40    Lunch break with symposium arranged by Novo Nordisk
                       Trond Methi: Diabetes and the Brain - The mysteries of the brain, consciousness, free will, cognitive

                       function, artificial intelligence, appetite regulation, metabolism and sleep

                       The Swedish Child Diabetes Foundation Awards

                       (chair: Johnny Ludvigsson)
       
13.40-14.20    Swedish Child Diabetes Foundation's Johnny Ludvigsson Nordic Prize
                       Per-Ola Carlsson, Uppsala
14.20-14.45    The Swedish Child Diabetes Foundation's Johnny Ludvigsson Prize to a Young Swedish Scientist

                       lecture
                       Araz Rawshani, Göteborg

14.45-15.00   Break

                       Diabetes epidemiology

                       (chairs: Lars Christian Stene, Sofia Carlsson)
       
15.00-15.45   Ed Gregg, London: New Divides, Directions, and Demands in the Global Type 2 Diabetes Epidemic

15.45-16.20    Oral abstract presentations


          O9:       Paz LD Ruiz: Epidemiology of covid-19 in people with diabetes in Norway: a nationwide register-

                       based study of infection, hospitalization, vaccination and mortality
          O10:     Vera Vik Bjarkø: The prevalence and cardiovascular risk profile of undiagnosed diabetes in a

                       Norwegian population. The HUNT4 Survey 
          O11:     Katharina Herzog: Alterations in biomarkers of carbohydrate and lipid metabolism up to 20 years

                       before the diagnosis of type 1 diabetes – findings from the AMORIS cohort
          O12:     Emma Hedlund: Month of birth and risk of developing type 1 diabetes among children in the

                       Swedish national diabetes cohort, the BDD-study

16.20-16.30    Break

                            Novo Nordisk Foundation Lecture

16.30-16.40     Introduction by Anna Krook, Novo Nordisk Foundation
16.40-17.35     Kåre I. Birkeland, Oslo: Type 2 diabetes, insulin resistance and cardiovascular disease

17.50-18.30     The annual SSSD general assembly

 

Friday March 12

                             Obesity and metabolic syndrome

                             ​(chairs: Jørn Sagen, Hanne Løvdal Gulseth)

08.30-09.00     Mikael Rydén, Stockholm: Some novel aspects on white adipose tissue function in mice and men
09.00-09.30     Dag Hofsø, Tønsberg: When and how should we treat patients with type 2 diabetes with bariatric

                        surgery?
09.30-10.00     Simon Dankel, Bergen: Why does obesity lead to insulin resistance and diabetes?       

10.00-10.15     Break

                             Diabetes technology

                             (chairs: Sverre Christiansen, Stine L. Fougner)
       
10.15-10.45    Kirsten Nørgaard, Copenhagen: Evidence and experience with self-adjusting insulin pumps

                             Gestational diabetes

                             (chairs: Sverre Christiansen, Stine L. Fougner)

10.45-11.15    Elisabeth Mathiesen, Copenhagen: Insulin treatment in gestational diabetes


11.15-12.05   Oral abstract presentations

                      (chairs: Sondre V. Meling, Esben Søndergaard)

          O13:     Nicolas Fragoso-Bargas: Epigenome-wide association study (EWAS) of insulin resistance in

                       pregnancy
          O14:     Stine L. Fougner: The impact of gestational diabetes mellitus on pregnancy complications and

                       outcome in women with polycystic ovary syndrome
          O15:     Björn Morén: Small droplets and droplet cluster formation in human adipocytes – a possible site for

                       lipid transfer and lipid metabolism
          O16:     Mette Louise B.G. Kjærulff: Effect of intermittent fasting on insulin resistance and substrate

                       metabolism of the heart
          O17:     Camilla Skoglund: Increase of neutrophil extracellular traps as well as extracellular mitochondrial

                       and nuclear DNA in newly diagnosed type 1 diabetes children

          O18:     Amaya Lopez-Pascual: CEBPG, a novel beta cell transcription factor influences insulin secretion

12.15-13.15   Lunch break with symposium arranged by AstraZeneca

                      Peter Rossing, Steno Diabetes Center Copenhagen: Diabetes and chronic kidney disease

13.15-14.00   Oral abstract presentations

                      (chairs: Stine L. Fougner, Virginia Stone)
       
          O19:     Chandra Yogal: Prevalence of type 2 diabetes and risk factors among women in rural Nepal
          O20:     Sara Juul Mansachs: Neuropeptide Y autoantibodies in Danish Type 1 Diabetes patients
          O21:     Hugo Barcenilla: High-dimensional single cell analysis of immune populations in recent onset type 1

                       diabetes patients receiving GAD-alum injection into the lymph node 
          O22:     Anna-Maria Lampousi: Dietary factors and risk of islet autoimmunity and type 1 diabetes: a

                       systematic review and meta-analysis
          O23:     Jessica Edstorp: Tobacco use and interaction with HLA genotypes in the risk of latent autoimmune

                       diabetes in adults: results from two population-based studies
 

                   
                             Genetics

                             (chairs: Lars Christian Stene, Johan Fernø)
       
14.00-14.45   Marcel den Hoed, Uppsala: Functional follow-up of GWAS findings

14.45-15.00   Break

                             Awards

                             (chairs: Bjørn Olav Åsvold, Elin Pettersen Sørgjerd)
           
15.00-15.50   Knud Lundbæk Award lecture
                      Åke Lernmark, Malmö: Dissecting the etiology of autoimmune (type 1) diabetes
15.50-16.20   SSSD Young Investigator Awards
                      Simon Lecoutre: Glutamine links obesity to inflammation in human white adipose tissue
                      Ning Liang: Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via

                      activation of PPARα